Innovation in Phase 1 Clinical Development
Innovation in Phase 1 Clinical Development
June 25 – 27, 2012
TBA, Boston, MA
Short-Link: http://bit.ly/I96TIP
Reducing Costs of Your Studies & Eliminating Errors for a Smooth Transition to Phase 2 Development
While several strategies, such as outsourcing and strategic partnerships, have been tried and tested, there has been no definitive answer to resolve the financial dilemma that exists within clinical trials. Attend Innovation in Phase 1 Clinical Development to hear successful implementations of cost saving strategies. This phase 1 clinical trial event will help you transition to Phase 2 production faster and more cost effectively. You will hear case studies from the top pharmaceutical and biotech companies including Pfizer, Merck, GlaxoSmithKline, Bristol Meyers Squibb, Takeda Global R&D, Abbott Laboratories and more.
Visit http://bit.ly/I96TIP to view the brochure or to register.
Subject Areas: Pharmaceuticals, Health Care, Clinical Development
Pricing: Ranges from $ 499 to 1099
Contact:
IQPC
535, 5th Avenue, New York, NY 10017
Ashley Rowe, Phone: 646-378-6034, Mail: Ashley.Rowe@iqpc.com
